Side-by-side comparison of AI visibility scores, market position, and capabilities
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Pre-IPO secondary marketplace for private company shares; institutional-grade transactions for employee equity and early investor liquidity with Forge Data analytics.
Forge Global is a private securities marketplace providing liquidity solutions for shareholders of pre-IPO companies — including employees, early investors, and former executives — seeking to sell equity before a company goes public. Founded in 2018 and headquartered in San Francisco, Forge went public via SPAC merger in March 2022 and operates as the leading institutional-grade secondary marketplace for late-stage private company shares. The company's marketplace pairs sellers with institutional buyers including family offices, hedge funds, and accredited investors seeking pre-IPO allocations.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.